SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Arcolab plans to buy out Australian venture Ascent

17 Mar 2010 Evaluate

Generic drugs maker Strides Arcolab Ltd has informally offered to buy the remaining 43 per cent stake in its Australian venture, Ascent Pharmahealth Ltd. The final outcome is expected to be known in the next 90 days.

 

Ascent, now listed on the Australian Stock Exchange, would be de-listed. The Australian company has been valued at $100 million. For the 43 per cent share it plans to buy, Strides would make a cash offer of Australian $35 million (nearly Rs 145 crore at current exchange rates), proposing to buy the stake at a premium rate of $0.35 per share.

 

The Bangalore-based company plans to include Ascent's founder-CEO, Mr Dennis Bastas, as an equity participant in its formal offer and also retain the executive management team. The money for the acquisition would come both from company resources and debt.

 

The attraction in Ascent apparently lies in its large complementary generic medicine chest, besides prescribed and freely sold (OTC) skin care products. It is the fourth largest non-patent drug maker in that country. The plan, if it came through, would make Strides the largest Indian company there. Early this month, Strides bought back its Brazilian facility for $75 million from Aspen Pharmacare of South Africa.

crackcrack

Strides Pharma Scien Share Price

1000.70 6.80 (0.68%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×